Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-3 of 3 for Giant cell arteritis

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis

    Rochester, MN

  2. Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

    Rochester, MN

  3. A Study to Evaluate Advanced Ultrasound Techniques for Diagnosis of Giant Cell Arteritis

    Rochester, MN

.

Mayo Clinic Footer